Recent FDA Initiatives to Support Development of Individualized Cell and Gene Therapies and Rare Disease Therapies

​​​​​​​Last month, FDA issued a Request for Information (RFI) in the Federal Register seeking information and comments from interested stakeholders regarding “critical scientific challenges and opportunities to advance the development of individualized cellular and gene therapies (CGTs).”…
By: Goodwin